CIBC World Market
TARS icon

CIBC World Market’s Tarsus Pharmaceuticals TARS Stock Holding History

CIBC World Market’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Sell
12,300
-200
-2% -$12.8K ﹤0.01% 1077
2026
Q1 		$877K Buy
+12,500
New +$873K ﹤0.01% 978
2024
Q2 		– Sell
-150,000
Closed -$5.45M – 1359
2024
Q1 		$5.45M Buy
+150,000
New +$4.41M 0.01% 436

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CIBC World Market's TARS Position: Q2 2026 in Review

CIBC World Market reduced its Tarsus Pharmaceuticals (TARS) stake by 1.6% in Q2 2026, selling an estimated $12.8K and leaving 12,300 shares worth $774K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

CIBC World Market first reported a position in TARS in Q1 2024 and has held it in 3 quarters since. The position peaked at $5.45M in Q1 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • CIBC World Market held 12,300 shares of Tarsus Pharmaceuticals worth $774K as of Q2 2026.
  • CIBC World Market sold 200 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $12.8K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1077 holding.
  • CIBC World Market first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • CIBC World Market's Tarsus Pharmaceuticals position peaked at $5.45M in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.